Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Misa Fujii"'
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 20, p 6616 (2023)
The clinical requirement for a good esthetic result for immediate implant placement is the absence of dehiscence in the anterior facial alveolar bone. In the presence of dehiscence, it is recommended to use a connective tissue graft in addition to im
Externí odkaz:
https://doaj.org/article/6d8a213c92e543d9a0580ae0d996ae88
Autor:
Yasunori, Shikada, Yasunori, Emi, Takuro, Kometani, Toshiaki, Ochiai, Misa, Fujii, Yoko, Noda, Mie, Kajiwara, Sanae, Miyazaki, Shinichi, Asonuma, Minami, Mori
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 46(11)
We retrospectively examined 106 cases of tapentadol use in Japan in August 2014 for cancer pain at our hospital.The advantage of the opioid medication tapentadol is that its introduction is suitable in patients undergoing anti-cancer treatment becaus
Autor:
Yasunori, Shikada, Yasunori, Emi, Takuro, Kometani, Toshiaki, Ochiai, Misa, Fujii, Yoko, Noda, Mie, Kajiwara, Munehiko, Ikeda, Shinichi, Asonuma, Minami, Mori
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 45(7)
Opioid-induced constipation(OIC)occurs with high frequency in patients with cancer undergoing pain treatment using opioids. Osmotic or irritant laxatives are usually used to prevent OIC. Recently, naldemedine has become operational for OIC. Although
Autor:
Yasunori, Shikada, Yasunori, Emi, Takuro, Kometani, Toshiaki, Ochiai, Misa, Fujii, Yoko, Noda, Mie, Kajiwara, Munehiko, Ikeda, Shinichi, Asonuma, Minami, Mori
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 45(4)
Breakthrough cancer pain is divided into "predictable breakthrough pain" and "unpredictable breakthrough pain". Uncontrolled breakthrough pain in cancer negatively affects the quality of life of the patients. The short-acting opioid(SAO) requires con